BioSpace News Archive

The U.S. Food and Drug Administration today posted a warning letter to Alkermes, Inc. of Massachusetts, for misbranding the drug Vivitrol (an extended-release injection formulation of naltrexone) by omitting warnings about the most serious risks associated with the drug from promotional materials

A recent study by the National Institute for Occupational Health and Safety revealed that cancer is currently the leading cause of death among firefighters.

Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio” or the “Company”) announced today the appointment of Professor Michael Levitt of Stanford University to be the Chief Consultant of Anpac Bio’s Innovation and Technical Advisory Board.

Young Living, the world leader in essential oils, announced a new partnership with the Golden Einkorn Farm in Sault, located in the French region of Provence.

The Research Partnership to Secure Energy for America (RPSEA), a consortium of premier U.S. energy companies, research universities, independent research organizations and foundations collaborating with state and federal agencies, announced it is dedicating its research expertise and academic resources to launch a national collaborative research program

The United States faces a crisis in providing complex care for high-need, high-cost individuals—people who often suffer economic, mental and physical challenges.

DTN, an independent source of insights, analysis and decision-support solutions, has acquired MetStat, an industry leader in precipitation analysis and analytics.

The Washington Poison Center has assisted Washingtonians for over 60 years through its toll-free Poison Helpline (1-800-222-1222), available 24/7/365

The proceeds will be used to support further product development and clinical studies for GI Window’s patented technology in the next generation of clinical procedures and tissue fusion.

ImpediMed Limited, a medical software technology company that non-invasively measures, monitors and manages fluid status and tissue composition using bioimpedance spectroscopy, recently announced the issuance of a further 510 clearance for SOZO® by the U.S. Food and Drug Administration.